AstraZeneca AZN announces its next round of earnings this Thursday, July 30. Here is Benzinga's everything-that-matters guide for this Thursday's Q2 earnings announcement.
Earnings and Revenue
Wall Street expects EPS of $0.44 and sales around $6.28 billion. In the same quarter last year, AstraZeneca reported earnings per share of $0.730 on sales of $5.82 billion. If the company were to report in-line earnings when it publishes results Thursday, earnings would be down 39.73%. Revenue would be up 6.44% from the year-ago period. AstraZeneca's reported EPS has stacked up against analyst estimates in the past like this:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | 0.47 | 0.59 | 0.45 | 0.29 |
| EPS Actual | 1.05 | 0.89 | 0.99 | 0.73 |
| Revenue Estimate | 5.90 B | 6.75 B | 6.18 B | 5.51 B |
| Revenue Actual | 6.35 B | 6.66 B | 6.41 B | 5.82 B |
Stock Performance
Shares of AstraZeneca were trading at $56.3 as of July 29. Over the last 52-week period, shares are up 28.27%. Given that these returns are generally positive, long-term shareholders are probably happy going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. AstraZeneca is scheduled to hold the call at 06:45:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/oeiczsvt
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
